STOCK TITAN

BIO-TECHNE TO PRESENT AT UPCOMING INVESTOR CONFERENCES

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Bio-Techne (NASDAQ: TECH) has announced that its President and CEO, Kim Kelderman, will present at several upcoming investor conferences. These include the William Blair 44th Annual Growth Conference on June 4, 2024, the Jefferies Global Healthcare Conference on June 6, 2024, and the Goldman Sachs 45th Annual Global Healthcare Conference on June 11, 2024. Each presentation will be accessible via a live webcast on Bio-Techne's Investor Relations website.

Positive
  • Bio-Techne's CEO will present at three major investor conferences, potentially increasing visibility and investor interest.
  • Live webcasts of the presentations will be available, providing transparency and accessibility for all investors.
Negative
  • The press release lacks specific details on new business developments, products, or financial performance.

MINNEAPOLIS, May 31, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Kim Kelderman, President and Chief Executive Officer will present at the following investor conferences:

William Blair 44th Annual Growth Conference
June 4, 2024
9:20 AM CDT

Jefferies Global Healthcare Conference
June 6, 2024
9:30 AM EDT

Goldman Sachs 45th Annual Global Healthcare Conference
June 11, 2024
9:20 AM EDT

A live webcast of the presentations can be accessed via the IR Calendar page of Bio-Techne's Investor Relations website at https://investors.bio-techne.com/ir-calendar.

About Bio-Techne 
Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. They aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. With thousands of products in its portfolio, Bio-Techne generated over $1.1 billion in net sales in fiscal 2023 and has approximately 3,100 employees worldwide. For more information on Bio-Techne and its brands, please visit https://www.bio-techne.com or follow the Company on social media at: FacebookLinkedInTwitter or YouTube.

Contact:

David Clair, Vice President, Investor Relations & Corporate Development


david.clair@bio-techne.com


612-656-4416  

Bio-Techne Logo (PRNewsfoto/Bio-Techne Corporation)

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/bio-techne-to-present-at-upcoming-investor-conferences-302157900.html

SOURCE Bio-Techne Corporation

FAQ

When will Bio-Techne present at the William Blair 44th Annual Growth Conference?

Bio-Techne will present at the William Blair 44th Annual Growth Conference on June 4, 2024, at 9:20 AM CDT.

When is Bio-Techne's presentation at the Jefferies Global Healthcare Conference?

Bio-Techne will present at the Jefferies Global Healthcare Conference on June 6, 2024, at 9:30 AM EDT.

When is Bio-Techne presenting at the Goldman Sachs 45th Annual Global Healthcare Conference?

Bio-Techne will present at the Goldman Sachs 45th Annual Global Healthcare Conference on June 11, 2024, at 9:20 AM EDT.

Where can I access the live webcasts of Bio-Techne's presentations?

The live webcasts of Bio-Techne's presentations can be accessed via the IR Calendar page on Bio-Techne's Investor Relations website.

Bio-Techne Corporation

NASDAQ:TECH

TECH Rankings

TECH Latest News

TECH Stock Data

12.34B
157.59M
0.97%
102.11%
3.44%
Biological Product (except Diagnostic) Manufacturing
Manufacturing
Link
United States of America
MINNEAPOLIS